Children’s asthma drug not beneficial enough – NICE – Nursing Times

Children's asthma drug not beneficial enough – NICE
Nursing Times
The asthma drug omalizumab (Xolair) does not produce enough benefits in children under 12 to justify it being prescribed by the NHS, the National Institute

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *